½ÃÀ庸°í¼­
»óǰÄÚµå
1274665

¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå º¸°í¼­(2023³â)

Anal Fissure Treatment Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Ä¡¿­ Ä¡·á ¼¼°è ½ÃÀåÀº 2022³â 12¾ï ´Þ·¯¿¡¼­ 2023³â 13¾ï ´Þ·¯¿¡ ´ÞÇϰí, ¿¬Æò±Õ 9.0% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î´Â Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ ¼¼°è °æÁ¦ ȸº¹ °¡´É¼ºÀ» È¥¶õ¿¡ ºü¶ß·È½À´Ï´Ù. ÀÌ ¾ç±¹ °£ÀÇ ÀüÀïÀº ¿©·¯ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý »ó½Â, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁ® Àüü »óǰ°ú ¼­ºñ½º¿¡ ´ëÇÑ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸ÄÑ ¼¼°è ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Ä¡¿­ Ä¡·á ½ÃÀåÀº 2027³â±îÁö CAGR 8.4%·Î ¼ºÀåÇÏ¿© 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì´Â 2022³â Ä¡¿­ Ä¡·á ½ÃÀå¿¡¼­ °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀÌ µÉ °ÍÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ä¡¿­ Ä¡·á ½ÃÀå º¸°í¼­´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, Áßµ¿ ¹× µ¿À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

³ëÀÎ Àα¸ Áõ°¡¿Í °Ç°­¿¡ ÇØ·Î¿î »ýȰ½À°üÀº ÇâÈÄ Ä¡¿­ Ä¡·á ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎ Àα¸´Â 65¼¼ ÀÌ»ó Àα¸·Î Á¤ÀǵǸç, Àüü Àα¸¿Í ³ëÀÎ Àα¸ ¹× û¼Ò³â Àα¸ÀÇ ºñÀ²·Î °è»êµË´Ï´Ù. ºÒ°Ç°­ÇÑ »ýȰ½À°üÀº °Ç°­À» ÇØÄ¡´Â ÇൿÀ» ÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í ºÒ°Ç°­ÇÑ »ýȰ½À°üÀ¸·Î ÀÎÇØ ³ëÈ­¿Í ½Ä½À°ü Àå¾Ö·Î ÀÎÇØ °ý¾à±ÙÀÌ ¾ã¾ÆÁö°Å³ª ²÷¾îÁö±â ¶§¹®¿¡ Ä¡¿­ Ä¡·á°¡ ÇÊ¿äÇÏ°Ô µË´Ï´Ù. ¿¹¸¦ µé¾î, ½ºÀ§½º¿¡ º»ºÎ¸¦ µÐ ±¹Á¦ °øÁߺ¸°Ç Àü¹®±â°üÀÎ ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2021³â¿¡´Â 60¼¼ ÀÌ»ó Àα¸°¡ 5¼¼ ¹Ì¸¸ ¾î¸°À̺¸´Ù ¸¹À» °ÍÀ̸ç, 2050³â¿¡´Â 12%¿¡¼­ 22%±îÁö Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¶ÇÇÑ, ½Ä½À°ü Àå¾Ö·Î ÀÎÇÑ ÇÇÇÒ ¼ö ÀÖ´Â »ç¸ÁÀÚ ¼ö´Â 2021³â¿¡´Â 930¸¸ ¸í¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. µû¶ó¼­ ³ëÀÎ Àα¸ Áõ°¡¿Í °Ç°­¿¡ ÇØ·Î¿î »ýȰ ½À°üÀÌ Ä¡¿­ Ä¡·á ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

º¯ºñ ¹ß»ý·ü Áõ°¡´Â ÇâÈÄ Ä¡¿­ Ä¡·á ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º¯ºñ´Â ´ëº¯ÀÌ µüµüÇϰí, °ÇÁ¶Çϰí, Åë°úÇÏ±â ¾î·Æ°í, ¹èº¯ Ƚ¼ö°¡ ÀûÀº °ÍÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀÔ´Ï´Ù. º¯ºñ¿¡´Â ÅëÁõÀ» µ¿¹ÝÇÏ´Â º¯ºñ ¿Ü¿¡µµ º¹ºÎ ÆØ¸¸°¨, ºÒ¾È°¨, ¹«±â·Â°¨ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ º¯ºñ ȯÀÚ¿¡°Ô¼­ ÈçÈ÷ ³ªÅ¸³ª´Â Ç×¹® Á¡¸·ÀÇ ¼Õ»óÀº Ä¡·çÀÇ ¿øÀÎÀÌ µÇ¹Ç·Î Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. µû¶ó¼­ º¯ºñ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ »ý¹° ÀÇÇÐ µµ¼­°ü ÀÎ ±¹¸³ ÀÇÇÐ µµ¼­°ü¿¡ µû¸£¸é 2021 ³â º¯ºñÀÇ ¼¼°è À¯º´·üÀº 12%¿¡¼­ 19%·Î º¯ºñ °Ë»ç¿¡ ¿¬°£ ¾à 70¾ï ´Þ·¯°¡ ¼Ò¿äµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ 2020³â¿¡´Â ºÏ¹Ì¿¡¼­ ¸¸¼º º¯ºñ°¡ ¾à 6,300¸¸ ¸í¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. µû¶ó¼­ º¯ºñÀ² Áõ°¡´Â Ä¡¿­ Ä¡·á ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Ä¡¿­ Ä¡·á ½ÃÀå Æ¯Â¡

Á¦3Àå Ä¡¿­ Ä¡·á ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå Ä¡¿­ Ä¡·á ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • COVID-19¿¡ ÀÇÇÑ Ä¡¿­ Ä¡·á ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ Ä¡¿­ Ä¡·á ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • °íÀÎÇ÷¹À̼ÇÀÌ Ä¡¿­ Ä¡·á ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå Ä¡¿­ Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå Ä¡¿­ Ä¡·á ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Topical Nitroglycerin
  • Calcium Channel Blockers
  • Stool Softeners
  • ±âŸ À¯Çü
  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Topical
  • Oral
  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Ŭ¸®´Ð
  • º´¿ø
  • ±âŸ ¿ëµµ

Á¦7Àå Ä¡¿­ Ä¡·á ½ÃÀå : Áö¿ª ¹× ±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, Áö¿ªº°, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°èÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ±¹°¡º°, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, ±ÔÁ¦, ±ÔÁ¦±â°ü, ÁÖ¿ä ´Üü, °ú¼¼¾×, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • Áß±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • Áß±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå ÀεµÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ÀεµÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀεµÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ»ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ÀϺ»ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ»ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • È£ÁÖÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • Àεµ³×½Ã¾ÆÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾ÆÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • Çѱ¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ¼­À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • ¼­À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ¿µ±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • µ¶ÀÏÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ÇÁ¶û½ºÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½ºÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • µ¿À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • µ¿À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾ÆÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ·¯½Ã¾ÆÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾ÆÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ºÏ¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • ºÏ¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ¹Ì±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • ¹Ì±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ³²¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • ³²¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹ÌÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁúÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ºê¶óÁúÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁúÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • Áßµ¿ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • Áßµ¿ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä«ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå

  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¡¿­ Ä¡·á ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå Ä¡¿­ Ä¡·á ½ÃÀå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

  • Ä¡¿­ Ä¡·á ½ÃÀå °æÀï ±¸µµ
  • Ä¡¿­ Ä¡·á ½ÃÀå ±â¾÷ °³¿ä
    • SRS Life Sciences Inc.
    • Healthy Life Pharma Private Limited
    • Eisai Co. Ltd.
    • AstraZeneca Plc.
    • Bayer AG

Á¦28Àå Ä¡¿­ Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦29Àå Ä¡¿­ Ä¡·á ½ÃÀå Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦30Àå ºÎ·Ï

LSH 23.05.25

“Anal Fissure Treatment Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anal fissure treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anal fissure treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The anal fissure treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Topical Nitroglycerin; Calcium Channel Blockers; Stool Softeners; Other Types
  • 2) By Route of Administration: Topical; Oral
  • 3) By Application: Clinics; Hospitals; Other Applications
  • Companies Mentioned: SRS Life Sciences Inc.; Healthy Life Pharma Private Limited; Eisai Co. Ltd.; AstraZeneca Plc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the anal fissure treatment market are SRS Life Sciences Inc., Healthy Life Pharma Private Limited, Eisai Co. Ltd., AstraZeneca Plc., Bayer AG, Novasep, Geri-care Pharmaceuticals Corp., Abbott Laboratories, GlaxoSmithKline Plc., Valeant Pharmaceuticals International Inc., Taro Pharmaceutical Industries Ltd., Cook Pharmica LLC, Pfizer Inc., Taj Pharmaceuticals Limited, Troikaa Pharmaceuticals Ltd., Purdue Pharma LP, and Allergan Inc.

The global anal fissure treatment market is expected to grow from $1.20 billion in 2022 to $1.30 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anal fissure treatment market is expected to grow to $1.80 billion in 2027 at a CAGR of 8.4%.

The anal fissure treatment market includes revenues earned by entities by providing medications such as ointments and therapies for anal fissure. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Anal fissure treatment refers to healing of small tear in the thin, moist tissue that lines the anus with help of practices like using sitz bath or taking stool softeners. They are used to calm the sphincter muscles and promote healing of the anal fissure.

North America was the largest region in the anal fissure treatment market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anal fissure treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The major types of anal fissure treatments are topical nitroglycerin, calcium channel blockers, stool softeners, and others. Topical nitroglycerin is an ointment used to treat chronic anal fissures and reduce moderate to severe discomfort. This medicine belongs to a member of the nitrate drugs family. Topical and oral are the major routes of administration involved, which are used in several applications, such as clinics, hospitals, and others.

An increasing elderly population and unhealthy lifestyles are expected to propel the anal fissure treatment market going forward. The elderly population, defined as those 65 and older, is computed as the ratio of the total population to the total elderly and juvenile populations. An unhealthy lifestyle is one in which a person practices behaviors that are harmful to their health. The increasing elderly population and unhealthy lifestyle will result in thinning and tearing of the internal sphincter because of age and poor diet, requiring anal fissure treatment. For instance, in 2021, according to the World Health Organization, a Switzerland-based specialized agency responsible for international public health, the number of people aged 60 and over outnumbered children younger than 5 years in 2020, and it is expected to grow by 12% to 22% by 2050. Further, the total number of avoidable deaths that have been attributed to poor dietary composition was 9.3 million in 2021. Therefore, the increasing elderly population and unhealthy lifestyle are driving the anal fissure treatment market.

Increasing constipation rates are expected to propel the anal fissure treatment market going forward. Constipation is a condition characterized by hard, dry, and difficult-to-pass stools and infrequent bowel motions. Constipation that causes pain, as well as feeling bloated, uneasy, and lethargic, are possible signs. Anus lining damage, which most frequently occurs in constipated patients, leads to anal fissures, requiring treatment. Thus, increasing constipation population will propel the market growth. For instance, in 2021, according to the National Library of Medicine, a US-based biomedical library, the global prevalence of constipation was 12% to 19% in 2021, and about $7 billion annually were spent on testing for constipation. Further, in 2020, chronic constipation affected approximately 63 million people in North America. Therefore, the increasing constipation rate is driving the anal fissure treatment market.

In July 2021, AstraZeneca Plc., a UK-based pharmaceutical and biotechnology company that focuses on the development and commercialization of prescription medicines, acquired Alexion Pharmaceuticals Inc. for an undisclosed amount. Through this acquisition, combined resources with Alexion's are expected to expand AstraZeneca's entry into medicines for rare diseases and discovery and development of medicines. Alexion Pharmaceuticals Inc. is a US-based biopharmaceutical company focused on developing life-changing therapies.

The countries covered in the anal fissure treatment market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The anal fissure treatment market research report is one of a series of new reports from The Business Research Company that provides anal fissure treatment market statistics, including anal fissure treatment industry global market size, regional shares, competitors with a anal fissure treatment market share, detailed anal fissure treatment market segments, market trends and opportunities, and any further data you may need to thrive in the anal fissure treatment industry. This anal fissure treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Anal Fissure Treatment Market Characteristics

3. Anal Fissure Treatment Market Trends And Strategies

4. Anal Fissure Treatment Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Anal Fissure Treatment Market
  • 4.2. Ukraine-Russia War Impact On Anal Fissure Treatment Market
  • 4.3. Impact Of High Inflation On Anal Fissure Treatment Market

5. Anal Fissure Treatment Market Size And Growth

  • 5.1. Global Anal Fissure Treatment Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Anal Fissure Treatment Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Anal Fissure Treatment Market Segmentation

  • 6.1. Global Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Topical Nitroglycerin
  • Calcium Channel Blockers
  • Stool Softeners
  • Other Types
  • 6.2. Global Anal Fissure Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Topical
  • Oral
  • 6.3. Global Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Clinics
  • Hospitals
  • Other Applications

7. Anal Fissure Treatment Market Regional And Country Analysis

  • 7.1. Global Anal Fissure Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Anal Fissure Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Anal Fissure Treatment Market

  • 8.1. Asia-Pacific Anal Fissure Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Anal Fissure Treatment Market

  • 9.1. China Anal Fissure Treatment Market Overview
  • 9.2. China Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Anal Fissure Treatment Market

  • 10.1. India Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Anal Fissure Treatment Market

  • 11.1. Japan Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Anal Fissure Treatment Market

  • 12.1. Australia Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Anal Fissure Treatment Market

  • 13.1. Indonesia Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Anal Fissure Treatment Market

  • 14.1. South Korea Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Anal Fissure Treatment Market

  • 15.1. Western Europe Anal Fissure Treatment Market Overview
  • 15.2. Western Europe Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Anal Fissure Treatment Market

  • 16.1. UK Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Anal Fissure Treatment Market

  • 17.1. Germany Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Anal Fissure Treatment Market

  • 18.1. France Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Anal Fissure Treatment Market

  • 19.1. Eastern Europe Anal Fissure Treatment Market Overview
  • 19.2. Eastern Europe Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Anal Fissure Treatment Market

  • 20.1. Russia Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Anal Fissure Treatment Market

  • 21.1. North America Anal Fissure Treatment Market Overview
  • 21.2. North America Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Anal Fissure Treatment Market

  • 22.1. USA Anal Fissure Treatment Market Overview
  • 22.2. USA Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Anal Fissure Treatment Market

  • 23.1. South America Anal Fissure Treatment Market Overview
  • 23.2. South America Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Anal Fissure Treatment Market

  • 24.1. Brazil Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Anal Fissure Treatment Market

  • 25.1. Middle East Anal Fissure Treatment Market Overview
  • 25.2. Middle East Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Anal Fissure Treatment Market

  • 26.1. Africa Anal Fissure Treatment Market Overview
  • 26.2. Africa Anal Fissure Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Anal Fissure Treatment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Anal Fissure Treatment Market Competitive Landscape And Company Profiles

  • 27.1. Anal Fissure Treatment Market Competitive Landscape
  • 27.2. Anal Fissure Treatment Market Company Profiles
    • 27.2.1. SRS Life Sciences Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Healthy Life Pharma Private Limited
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Eisai Co. Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. AstraZeneca Plc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Bayer AG
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Anal Fissure Treatment Market

29. Anal Fissure Treatment Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦